170 HARBOR WAY, SUITE 300, SOUTH SAN FRANCISCO, CA
Files Preliminary Proxy Statement and Issues Open Letter to Shareholders
Provides Business Update and Reports First Quarter 2026 Financial Results
Appoints James Breitmeyer, M.D., Ph.D., to Board of Directors
Other Events
Announces Share Purchase Agreement for up to $25 Million with Lincoln Park Capital
Provides Business Update and Reports Full Year 2025 Financial Results
Termination of Material Definitive Agreement - Vaxart, Inc.
Provides Business Update and Reports Third Quarter 2025 Financial Results
FY 2025
Q3
Q2
Q1
FY 2024
Prospectus filed pursuant to Rule 424(b)(3)
Effectiveness Notice
S-1
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities Offered under a Shelf Registration
Preliminary Proxy Statement
Additional Proxy Materials
Additional Proxy Soliciting Materials
Statement of Changes in Beneficial Ownership
Initial Statement of Beneficial Ownership
Correspondence
Submission Upload